Key Points
The proportions of immune cells and autoimmune and virus-related genes change in pSS.
Cell communication of TGF-β and CD30 among immune cells was abnormal in pSS patients.
Single-cell TCR and BCR repertoires do not change much in pSS patients.
Abstract
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease that is estimated to affect 35 million people worldwide and is characterized by lymphocytic infiltration, elevated circulating autoantibodies, and proinflammatory cytokines. The key immune cell subset changes and the TCR/BCR repertoire alterations in pSS patients remain unclear. In this study, we sought to comprehensively characterize the transcriptional changes in PBMCs of pSS patients by single-cell RNA sequencing and single-cell V(D)J sequencing. Naive CD8+ T cells and mucosal-associated invariant T cells were markedly decreased but regulatory T cells were increased in pSS patients. There were a large number of differentially expressed genes shared by multiple subpopulations of T cells and B cells. Abnormal signaling pathways, including Ag processing and presentation, the BCR signaling pathway, the TCR signaling pathway, and Epstein–Barr virus infection, were highly enriched in pSS patients. Moreover, there were obvious differences in the CD30, FLT3, IFN-II, IL-1, IL-2, IL-6, IL-10, RESISTIN, TGF-β, TNF, and VEGF signaling networks between pSS patients and healthy controls. Single-cell TCR and BCR repertoire analysis showed that there was a lower diversity of T cells in pSS patients than in healthy controls; however, there was no significant difference in the degree of clonal expansion, CDR3 length distribution, or degree of sequence sharing. Notably, our results further emphasize the functional importance of αβ pairing in determining Ag specificity. In conclusion, our analysis provides a comprehensive single-cell map of gene expression and TCR/BCR profiles in pSS patients for a better understanding of the pathogenesis, diagnosis, and treatment of pSS.
Footnotes
This work was supported by grants from the National Natural Science Foundation of China (82101877), the China Postdoctoral Science Foundation (2021M691239), the Guangxi Natural Science Foundation (2019GXNSFBA245032), the Guangxi Science and Technology Plan Project (Gui Ke AD20238021), the Innovation Project of Guangxi Graduate Education (JGY2021140), the Guilin Science Research and Technology Development Project (20190218-5-5, 20210218-2), the Key Research and Development Program of Guangdong Province (2019B020229001), the Science and Technology Plan of Shenzhen (JCYJ20200109144218597), the Shenzhen Key Medical Discipline Construction Fund (SZXK011), the Science and Technology Plan of Shenzhen (JCYJ20180302145337935), and the Shenzhen Fund for Guangdong Provincial High-Level Clinical Key Specialties (SZGSP001).
The single-cell sequencing data have been submitted to the Genome Sequence Archive for Human under accession number HRA002337.
The online version of this article contains supplemental material.
- Received September 15, 2021.
- Accepted April 18, 2022.
- Copyright © 2022 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.